|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBOOKCENTRAL_ocn609861128 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr n||---||||| |
008 |
100427s2010 nyu o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDXCP
|d IDEBK
|d OCLCQ
|d CGU
|d OCLCQ
|d OCLCF
|d OCLCO
|d N$T
|d OCLCQ
|d UAB
|d OCLCQ
|d YDX
|d OCLCQ
|d SFB
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 748212304
|a 816379697
|
020 |
|
|
|a 9781420020038
|q (electronic bk.)
|
020 |
|
|
|a 142002003X
|q (electronic bk.)
|
020 |
|
|
|z 1282560980
|
020 |
|
|
|z 9781282560987
|
029 |
1 |
|
|a NZ1
|b 13876249
|
029 |
1 |
|
|a AU@
|b 000055734513
|
035 |
|
|
|a (OCoLC)609861128
|z (OCoLC)748212304
|z (OCoLC)816379697
|
050 |
|
4 |
|a RS55.2
|b .G456 2010
|
072 |
|
7 |
|a MMG, TDCW
|2 bicssc
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.19
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Shargel, Leon.
|
245 |
1 |
0 |
|a Generic Drug Product Development :
|b Specialty Drug Forms.
|
260 |
|
|
|a New York :
|b Informa Healthcare,
|c 2010.
|
300 |
|
|
|a 1 online resource (292 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a Explores the issues in providing evidence of pharmaceutical equivalence and bioequivalence for specialty drug products.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Preface; Contents; Chapter 1. Introduction; Chapter 2. Nonsystemically Absorbed Oral Drug Products; Chapter 3. Topical Drug Products -- Development, Manufacture, and Regulatory Issues; Chapter 4. Assessment of Topical Dosage Forms Intended for Local or Regional Activity; Chapter 5. Rectal Dosage Forms and Suppositories; Chapter 6. Nasal and INhalation Drug Products; Chapter 7. Locally Acting Nasal and inhalation Drug Products: Regulatory and Bioequivalence Perspective; Chapter 8. Transdermal Dosage Forms
|
505 |
8 |
|
|a Chapter 9. Pharmaceutical Development of Modified-Release Parenteral Dosage Forms Using Bioequivalence (BE), Quality by Design (QBD), and In Vitro In Vitro Correlation (IVIVC) Principles Chapter 10. Biosimilar Drug Products -- Manufacture and Quality ; Index; Color Insert ; Back Cover
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Generic drugs.
|
650 |
|
0 |
|a Drug development.
|
650 |
|
0 |
|a Drugs
|x Dosage forms.
|
650 |
|
0 |
|a Drugs
|x Therapeutic equivalency.
|
650 |
|
2 |
|a Drugs, Generic
|
650 |
|
2 |
|a Dosage Forms
|
650 |
|
2 |
|a Therapeutic Equivalency
|
650 |
|
6 |
|a Médicaments génériques.
|
650 |
|
6 |
|a Médicaments
|x Développement.
|
650 |
|
6 |
|a Médicaments
|x Formes pharmaceutiques.
|
650 |
|
6 |
|a Médicaments
|x Équivalence thérapeutique.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug development
|2 fast
|
650 |
|
7 |
|a Drugs
|x Dosage forms
|2 fast
|
650 |
|
7 |
|a Drugs
|x Therapeutic equivalency
|2 fast
|
650 |
|
7 |
|a Generic drugs
|2 fast
|
700 |
1 |
|
|a Kanfer, Isadore.
|
758 |
|
|
|i has work:
|a Generic drug product development (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGWMjV4BmmGHg3QdxYBCHC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|z 9780849377860
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1405502
|z Texto completo
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 15920265
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL510087
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 934969
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 256098
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3201439
|
994 |
|
|
|a 92
|b IZTAP
|